This effect may be related to the overexpression of angiotensin converting enzyme 2 (ACE2) in lung cancer compared to normal tissue, which is a key target for SARS-CoV-2 cell entry [97], and the suppressed immunity of cancer patients [98]. The gene discussed is ACE2; the disease is lung carcinoma.